COSCIENS Biopharma (CSCI)announced the appointment of Anna Biehn as Chief Executive Officer, CEO, effective May 5, 2025. Biehn is a global general management and marketing executive with over 25 years of experience across the consumer products and biosciences industries. She joins COSCIENS having most recently served as the Chief Financial Officer of NuTek Natural Ingredients, a clean-label and plant-based food ingredient company.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSCI:
- COSCIENS Biopharma Reports Revenue Growth and Strategic Repositioning
- COSCIENS Biopharma Faces Management Cease Trade Order Amid Filing Delays
- COSCIENS Biopharma Faces Potential Delay in Year-End Filings Due to Merger Complexities
- Cosciens Biopharma announces possible delay in filing 2024-end documents
- COSCIENS Biopharma Advances Avenanthramides to Phase 2a Trial